Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design
Structure · 2024
DOI: 10.1016/j.str.2024.05.011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Structure, 2024. Verfasst von Manjeet Mukherjee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Astex Pharmaceuticals, Cambridge CB4 0QA, UK. Electronic address: manjeet.mukherjee@astx.com. Hauptthemen laut MEDLINE: Protein Engineering, Drug Design, Cyclin-Dependent Kinases, Protein Kinase Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Astex Therapeutics Ltd.
Abstract (Originalsprache)
Cyclin dependent kinase 7 (CDK7) is an important therapeutic kinase best known for its dual role in cell cycle regulation and gene transcription. Here, we describe the application of protein engineering to generate constructs leading to high resolution crystal structures of human CDK7 in both active and inactive conformations. The active state of the kinase was crystallized by incorporation of an additional surface residue mutation (W132R) onto the double phosphomimetic mutant background (S164D and T170E) that yielded the inactive kinase structure. A novel back-soaking approach was developed to determine crystal structures of several clinical and pre-clinical inhibitors of this kinase, demonstrating the potential utility of the crystal system for structure-based drug design (SBDD). The crystal structures help to rationalize the mode of inhibition and the ligand selectivity profiles versus key anti-targets. The protein engineering approach described here illustrates a generally applicable strategy for structural enablement of challenging molecular targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Astex Pharmaceuticals, Cambridge CB4 0QA, UK. Electronic address: manjeet.mukherjee@astx.com.
- Astex Pharmaceuticals, Cambridge CB4 0QA, UK.
Förderung
- Astex Therapeutics Ltd
Zitieren
APA
Mukherjee, M., Day, P. J., Laverty, D., Bueren-Calabuig, J. A., Woodhead, A. J., Griffiths-Jones, C., Hiscock, S., East, C., Boyd, S., & O'Reilly, M. (2024). Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design. Structure. https://doi.org/10.1016/j.str.2024.05.011
Vancouver
Mukherjee M, Day PJ, Laverty D, Bueren-Calabuig JA, Woodhead AJ, Griffiths-Jones C, et al. Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design. Structure. 2024. doi:10.1016/j.str.2024.05.011
BibTeX
@article{Mukherjee2024,
author = {Mukherjee, Manjeet and Day, Philip J and Laverty, Duncan and Bueren-Calabuig, Juan A and Woodhead, Andrew J and Griffiths-Jones, Charlotte and Hiscock, Steve and East, Charlotte and Boyd, Susan and O'Reilly, Marc},
title = {Protein engineering enables a soakable crystal form of human CDK7 primed for high-throughput crystallography and structure-based drug design},
journal = {Structure},
year = {2024},
doi = {10.1016/j.str.2024.05.011}
}
EUVIMED